Sumatriptan 85 mg, in a rapidly dissolving form, with naproxen sodium 500 mg in a bilayer tablet, was approved as a combination tablet for the acute treatment of migraine by the US FDA on Apr 15 ...

Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on K ...

“Sumatriptan maximal daily dose is 200 mg ... very well around menstrual cycle migraine worsening, sometimes in the form of ‘mini-prevention’ for a few days,” says Riggins.